11:33 AM EST, 12/20/2024 (MT Newswires) -- Protagenic Therapeutics ( PTIX ) on Friday filed a registration statement with the US Securities and Exchange Commission for the potential sale of up to about 5.84 million shares by some selling stockholders from "time to time."

The company said it is not selling any stock under this prospectus.

Price: 0.63, Change: -0.02, Percent Change: -3.08